Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 26 10:24AM ET
3.93
Dollar change
-0.17
Percentage change
-4.15
%
Index- P/E- EPS (ttm)-0.08 Insider Own10.50% Shs Outstand10.86M Perf Week-12.67%
Market Cap29.68M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float- Perf Month-
Income-32.00M PEG- EPS next Q- Inst Own10.70% Short Float- Perf Quarter-
Sales1.30M P/S22.83 EPS this Y-10.70% Inst Trans- Short Ratio0.14 Perf Half Y-
Book/sh0.04 P/B98.25 EPS next Y- ROA-65.30% Short Interest0.01M Perf Year-
Cash/sh1.64 P/C2.39 EPS next 5Y- ROE-132.50% 52W Range3.86 - 50.82 Perf YTD-77.76%
Dividend Est.- P/FCF- EPS past 5Y- ROI-126.00% 52W High-92.27% Beta-
Dividend TTM- Quick Ratio1.10 Sales past 5Y- Gross Margin- 52W Low1.81% ATR (14)4.63
Dividend Ex-Date- Current Ratio1.30 EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility19.16% -
Employees- Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q18.20% Payout0.00% Rel Volume0.29 Prev Close4.10
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume61.05K Price3.93
SMA20-43.50% SMA50-43.50% SMA200-43.50% Trades Volume3,249 Change-4.15%
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.